| Symbol | Company | Weighting |
|---|---|---|
| ABVX | ABIVAX SA | 22.75% |
| EYPT | EYEPOINT INC | 3.21% |
| RVMD | REVOLUTION MEDICINES INC | 2.87% |
| INSM | INSMED INC | 2.40% |
| EWTX | EDGEWISE THERAPEUTICS | 2.25% |
| CYTK | CYTOKINETICS INC | 2.23% |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 2.19% |
| PCVX | VAXCYTE INC | 2.17% |
| IMVT | IMMUNOVANT INC | 2.08% |
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORPORATION | 1.99% |
| TVTX | TRAVERE THERAPEUTICS INC | 1.93% |
| PSNL | PERSONALIS | 1.86% |
| TARS | TARSUS PHARMACEUTICALS | 1.84% |
| DNLI | DENALI THERAPEUTICS INC. | 1.79% |
| GMED | GLOBUS MEDICAL INC CLASS A | 1.72% |
| AZN | ASTRAZENECA PLC | 1.66% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 1.58% |
| THC | TENET HEALTHCARE CORP | 1.55% |
| CRNX | CRINETICS PHARMACEUTICALS INC | 1.54% |
| HCA | HCA HOLDINGS INC | 1.53% |
| ARGX | ARGENX SE ADR | 1.52% |
| DYN | DYNE THERAPEUTICS, INC. | 1.51% |
| HALO | HALOZYME THERAPEUTICS INC | 1.49% |
| MCK | MCKESSON CORP | 1.45% |
| GKOS | GLAUKOS CORPORATION | 1.41% |
| ABBV | ABBVIE INC | 1.31% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.26% |
| TNDM | TANDEM DIABETES CARE INC | 1.25% |
| MDT | MEDTRONIC PLC | 1.24% |
| DHR | DANAHER CORP | 1.21% |
| REGN | REGENERON PHARMACEUTICALS | 1.18% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.16% |
| RGEN | REPLIGEN CORP | 1.15% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.15% |
| RMD | RESMED INC | 1.12% |
| BDX | BECTON DICKINSON & CO | 1.12% |
| SYK | STRYKER CORP | 1.08% |
| ALC | ALCON INC | 1.07% |
| UNH | UNITEDHEALTH GROUP INC | 1.03% |
| SNY | SANOFI- AVENTIS- ADR | 1.01% |
| VCEL | VERICEL CORP | 0.95% |
| ISRG | INTUITIVE SURGICAL INC | 0.95% |
| ELV | ELEVANCE HEALTH INC | 0.94% |
| DXCM | DEXCOM INC | 0.94% |
| ABT | ABBOTT LABORATORIES | 0.93% |
| KRRO | KORRO BIO | 0.89% |
| ADMA | ADMA BIOLOGICS, INC. | 0.88% |
| ZTS | ZOETIS INC | 0.84% |
| ICLR | ICON PLC | 0.82% |
| HUM | HUMANA INC | 0.78% |
| BSX | BOSTON SCIENTIFIC | 0.76% |
| SPRY | ARS PHARMACEUTICALS | 0.75% |
| SMMT | SUMMIT THERAPEUTICS INC. | 0.72% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 0.70% |
| SRPT | SAREPTA THERAPEUTICS INC | 0.58% |
| LENZ | LENZ THERAPEUTICS | 0.55% |
| CDXS | CODEXIS INC | 0.50% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 0.41% |
| WAT | WATERS CORP | 0.26% |
| AKROCV | CONTRA AKERO THERAPEUT | 0.00% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2026 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.